domino pizza inc buy pt model modest ep dilut accret refi also
modest food relief rais pt analyst stephen anderson full summari
ellington llc buy pt book valu impli ep vs dividend reiter
abeona inc buy pt avexi goe novarti valu abeona
corpor event call maxim salesperson inform
reed inc reed cover vendetti ndr san francisco ceo val stalowir mon apr
inc cover confer call presid scott colosi senior director
ir/financi report tonya robinson mon may
cover ndr boston cfo golder wed jun
corpor ctrl cover chokshi ndr boston ct nyc cfo mark novakovich mon-w
annual silicon valley bu tour host chokshi tue juli
profir energi inc pfie host jang ndr nyc ceo brendan hatch cfo ryan oviatt wed thur
tecogen inc tgen cover jang institut group dinner nyc boston ceo benjamin lock
head tgen ultera emiss technolog robert panora wed apr
model modest ep dilut accret
refi also modest food relief rais pt
maintain buy rate rais price target
follow today announc compani would
refin portion debt
view dpz refinanc announc modest posit long
term though expect compani pay short-term price rate certainti
also see relief commod cost near-term catalyst ep upsid
view dpz refinanc announc modest posit long term
though expect compani pay short-term price rate certainti
file sec morn said would issu million new
fixed-r debt would use retir million debt
refinanc includ million variable-r financ plan close
refinanc sometim june manag provid detail beyond
provid press releas expect addit comment
releas march result later month
howev exhibit demonstr potenti effect refinanc dpz
balanc sheet weight averag interest rate upon close estim
refinanc would add million new balanc sheet debt increas
dpz weight averag interest rate current assum
increas treasuri bond rate believ use
basi fix rate debt compar fixed-r issuanc
exhibit show net ep upsid refinanc assum
share buy-back beyond buyback model alreadi along
chang highlight exhibit would modestli dilut ep
accret ep
assum million increment new borrow estim dpz long-term
debt-to-ebitda ratio end would would high
end manag target rang howev estim retreat
end given outlook annual ebitda growth averag least
mid-teen princip repay
also see relief commod cost near-term catalyst ep upsid
dpz annual investor day present januari manag provid
guidanc food cost inflat exhibit show price mozzarella
chees sow pork increas late earli
retreat recent given feed price remain near multi-year low expect
price dairi pork modest headwind accord
model improv domest suppli chain cog ratio
food cost inflat add annual ep estim ep
upsid benign food cost outlook
still see upsid share even year-to-d gain equal
weight forward price-to-earnings multipl base multipl
five-year averag yield price target forward ev/ebitda
multipl base multipl five-year averag
yield price target sum-of-part yield price target
methodolog use base valuat year arriv price target
round
click full note
avexi goe novarti valu
novarti nv nr agre buy gene therapi compani avexi avx
nr repres premium friday close
question could next valuat abeona
valuat today vs other space like avexi bluebird hold
remain under-valued view addit abeona parallel
vector avexi use treat spinal muscular
atrophi sma newborn abeona use treat
children sanfilippo syndrom type develop nationwid
ye differ indic neurodegen diseas
intraven deliveri cross brain address
allow lower dose therapeut product
self-complimentari rapid onset high
demonstr posit safeti data similar dose even
lower abeona year well efficaci respect
differ keep mind differ diseas
differ deliv gene avexi right ahead clinic
month howev abeona present posit neurolog data
far one year vs avexi yr track
long-term data patient treat alreadi
addit second sanfilippo gt candid enrol
abeona pipelin includ next-gen aav target specif tissu
head pivot studi epidermolysi bullosa
conclus novarti agre buy avexi view
valid gene therapi cell therapi car-t regen med pois
integr therapeut landscap year come abeona
deep gt pipelin posit data rare diseas like sanfilippo
see compel valuat vs peer space
sanfilippo syndrom type iiia- cohort patient treat
vg/kg vg/kg vg/kg studi
expect enrol addit six nine patient cohort potenti serv
pivot program data continu demonstr posit safeti profil
stabil liver enzym immunogen lead fda allow abeona
enrol patient young six month old highest dose cohort reduct
urin heparin sulfat hs day day
day far cohort reduct across
time point csf hs cohort day reduc vs
cohort respect addit reduct liver swell cohort
far day biopot data continu suggest time
dose depend respons cohort brain architectur stabil one
year measur thalamu putamen volum improv
respect non-verb iq score month cohort demonstr
stabil vineland adapt behavior scale improv cohort
six month two three patient show evid stabil improv
cognit function measur non-verb iq score vineland
click full note
book valu impli ep vs
book valu versu impli ep
assum share buyback equal million share alreadi
announc versu previou estim
price target equat book valu
book valu unlik peer disclos book valu
monthli march book valu decemb
take account dividend share buyback equal
million share alreadi announc impli ep versu
previou ep estim like report earn first week
may
full implement new strategi complet yet begun implement
strategi transit credit invest portfolio non-ag mostli
experi credit asset trade hedg capabl accommod
non-reit structur best-in-class analyt strategi play
strength less favor strategi implement quickli
reli prudent direct origin
rais ep estim sinc impli ep
result came estim page updat earn model
maintain price target price target equat book valu
line relev peer view trade least line
peer given efc focu expertis non-agency/credit asset
potenti increas valu efc non-reit structur enabl
hedg trade without limit understand new tax
law distribut capit gain return capit continu
tax ordinari incom wherea distribut mortgag reit
tax ordinari incom rate
reiter buy rate next four quarter expect dividend
yield stock price appreci price target
result estim total return
click full note
maxim analyst coverag univers
sector coverag
care well
industri infrastructur
